These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 11315341)

  • 1. Nonsteroidal anti-inflammatory drugs in systemic lupus erythematosus.
    Østensen M; Villiger PM
    Lupus; 2001; 10(3):135-9. PubMed ID: 11315341
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nonsteroidal anti-inflammatory drugs in systemic lupus erythematosus.
    Ostensen M; Villiger PM
    Lupus; 2000; 9(8):566-72. PubMed ID: 11035430
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk:benefit ratio of nonsteroidal anti-inflammatory drugs in systemic lupus erythematosus.
    Horizon AA; Wallace DJ
    Expert Opin Drug Saf; 2004 Jul; 3(4):273-8. PubMed ID: 15268645
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nonsteroidal anti-inflammatory drugs exposure and the central nervous system.
    Auriel E; Regev K; Korczyn AD
    Handb Clin Neurol; 2014; 119():577-84. PubMed ID: 24365321
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Frequency of adverse drug reactions in patients with systemic lupus erythematosus.
    Pope J; Jerome D; Fenlon D; Krizova A; Ouimet J
    J Rheumatol; 2003 Mar; 30(3):480-4. PubMed ID: 12610805
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Celecoxib for systemic lupus erythematosus: case series and literature review of the use of NSAIDs in SLE.
    Lander SA; Wallace DJ; Weisman MH
    Lupus; 2002; 11(6):340-7. PubMed ID: 12139371
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disease specific problems related to drug therapy in pregnancy.
    Ostensen M
    Lupus; 2004; 13(9):746-50. PubMed ID: 15485116
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug-induced lupus erythematosus.
    Vedove CD; Del Giglio M; Schena D; Girolomoni G
    Arch Dermatol Res; 2009 Jan; 301(1):99-105. PubMed ID: 18797892
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of the nonsteroidal anti-inflammatory drug literature for potential developmental toxicity in rats and rabbits.
    Cook JC; Jacobson CF; Gao F; Tassinari MS; Hurtt ME; DeSesso JM
    Birth Defects Res B Dev Reprod Toxicol; 2003 Feb; 68(1):5-26. PubMed ID: 12852480
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serositis related to systemic lupus erythematosus: prevalence and outcome.
    Man BL; Mok CC
    Lupus; 2005; 14(10):822-6. PubMed ID: 16302677
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment. Corticosteroids and anti-inflammatory drugs.
    Kimberly RP
    Rheum Dis Clin North Am; 1988 Apr; 14(1):203-21. PubMed ID: 3041489
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Medical therapy for systemic lupus erythematosus.
    Taylor JK; McMurray RV
    J Miss State Med Assoc; 2011 Feb; 52(2):39-43. PubMed ID: 21387869
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Should low-dose aspirin also be a background therapy for all patients with systemic lupus erythematosus (SLE)?
    Malaviya AN; Mourou M
    Lupus; 2000; 9(7):561-2. PubMed ID: 11035427
    [No Abstract]   [Full Text] [Related]  

  • 14. Renal effects of indomethacin in patients with systemic lupus erythematosus.
    ter Borg EJ; de Jong PE; Meijer S; Kallenberg CG
    Nephron; 1989; 53(3):238-43. PubMed ID: 2677808
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tissue factor activity in patients with systemic lupus erythematosus: association with disease activity.
    Segal J; Kickler T; Petri M
    J Rheumatol; 2000 Dec; 27(12):2827-32. PubMed ID: 11128671
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Psychiatric manifestations of lupus erythematosus systemic and Sjogren's syndrome].
    Ampélas JF; Wattiaux MJ; Van Amerongen AP
    Encephale; 2001; 27(6):588-99. PubMed ID: 11865567
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictors of cognitive dysfunction in patients with systemic lupus erythematosus.
    McLaurin EY; Holliday SL; Williams P; Brey RL
    Neurology; 2005 Jan; 64(2):297-303. PubMed ID: 15668428
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Progress and perspectives in the treatment of systemic lupus erythematosus].
    Robak E; Sysa-Jedrzejowska A; Wozniacka A
    Przegl Lek; 2005; 62(9):894-9. PubMed ID: 16541725
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Histological antiphospholipid-associated nephropathy versus lupus nephritis in patients with systemic lupus erythematosus: an observational cross-sectional study with longitudinal follow-up.
    Gerhardsson J; Sundelin B; Zickert A; Padyukov L; Svenungsson E; Gunnarsson I
    Arthritis Res Ther; 2015 Apr; 17(1):109. PubMed ID: 25927214
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NSAID usage patterns by rheumatologists in the treatment of SLE.
    Wallace DJ; Metzger AL; Klinenberg JR
    J Rheumatol; 1989 Apr; 16(4):557-60. PubMed ID: 2664175
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.